EA201491300A1 - Композиция для назального применения с улучшенной стабильностью - Google Patents
Композиция для назального применения с улучшенной стабильностьюInfo
- Publication number
- EA201491300A1 EA201491300A1 EA201491300A EA201491300A EA201491300A1 EA 201491300 A1 EA201491300 A1 EA 201491300A1 EA 201491300 A EA201491300 A EA 201491300A EA 201491300 A EA201491300 A EA 201491300A EA 201491300 A1 EA201491300 A1 EA 201491300A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- improved stability
- composition
- body application
- pharmaceutical composition
- application
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/164—Amides, e.g. hydroxamic acids of a carboxylic acid with an aminoalcohol, e.g. ceramides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4174—Arylalkylimidazoles, e.g. oxymetazolin, naphazoline, miconazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/525—Isoalloxazines, e.g. riboflavins, vitamin B2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0043—Nose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/186—Quaternary ammonium compounds, e.g. benzalkonium chloride or cetrimide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Otolaryngology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Изобретение относится к фармацевтической композиции с улучшенной стабильностью, предназначенной для местного, преимущественно для назального, предпочтительно для интраназального применения, а также к ее применению и устройству для применения, содержащему эту фармацевтическую композицию.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE102011122588 | 2011-12-30 | ||
DE102012005452A DE102012005452A1 (de) | 2011-12-30 | 2012-03-20 | Zusammensetzung für die nasale Applikation mit verbesserter Stabilität |
PCT/EP2012/003995 WO2013097911A1 (de) | 2011-12-30 | 2012-09-25 | Zusammensetzung für die nasale applikation mit verbesserter stabilität |
Publications (2)
Publication Number | Publication Date |
---|---|
EA201491300A1 true EA201491300A1 (ru) | 2014-10-30 |
EA024618B1 EA024618B1 (ru) | 2016-10-31 |
Family
ID=47665594
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EA201491300A EA024618B1 (ru) | 2011-12-30 | 2012-09-25 | Композиция для назального применения с улучшенной стабильностью |
Country Status (9)
Country | Link |
---|---|
EP (2) | EP2766008B1 (ru) |
DE (2) | DE102012005452A1 (ru) |
DK (1) | DK2766008T3 (ru) |
EA (1) | EA024618B1 (ru) |
ES (1) | ES2612652T3 (ru) |
GE (1) | GEP201706609B (ru) |
PL (1) | PL2766008T3 (ru) |
UA (1) | UA113749C2 (ru) |
WO (1) | WO2013097911A1 (ru) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE202012005650U1 (de) * | 2012-05-14 | 2013-05-15 | Maria Clementine Martin Klosterfrau Vertriebsgesellschaft Mbh | Kombinationstherapeutikum für die Behandlung von Rhinitis |
DE202014105553U1 (de) * | 2014-08-18 | 2015-08-20 | Maria Clementine Martin Klosterfrau Vertriebsgesellschaft Mbh | Cineolhaltige Zusammensetzung für die nasale Applikation |
DE202017104738U1 (de) * | 2017-07-31 | 2018-08-01 | Maria Clementine Martin Klosterfrau Vertriebsgesellschaft Mbh | Neue Zusammensetzung für die nasale Applikation |
WO2019125330A2 (en) * | 2017-08-10 | 2019-06-27 | Eli̇xi̇r İlaç Araştirma Ve Geli̇şti̇rme A.Ş. | Nasal decongestant compositions comprising dexpanthenol and sodium hyaluronate |
EP3827818A1 (en) * | 2019-11-26 | 2021-06-02 | Warszawskie Zaklady Farmaceutyczne Polfa S.A. | Ophthalmic composition |
WO2023046590A1 (en) * | 2021-09-22 | 2023-03-30 | Jadran - Galenski Laboratorij D.D. | An improved pharmaceutical composition for nasal use, preparation, and use thereof |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5346886A (en) | 1993-11-15 | 1994-09-13 | John Lezdey | Topical α-1-antitrypsin, non-aqueous lipid miscible, benzalkonium chloride compositions for treating skin |
DE19549421C2 (de) * | 1995-11-10 | 1999-11-18 | Klosterfrau Mcm Vetrieb Gmbh | Pharmazeutische Zubereitung zur Behandlung akuter Rhinitiden |
DE19541919C2 (de) | 1995-11-10 | 1997-11-20 | Klosterfrau Mcm Vetrieb Gmbh | Pharmazeutische Zubereitung zur Behandlung akuter Rhinitiden |
DE10000612A1 (de) * | 2000-01-10 | 2001-07-19 | Min Becker | Flüssigkeitspräparate für Augen- und Nasen-Tropfen bzw. Nasenspray ohne Konservierungsmittel |
DE10337186A1 (de) | 2003-08-13 | 2005-03-17 | Merck Patent Gmbh | Wässrige Wirkstoff-Lösung |
DE20318634U1 (de) | 2003-11-13 | 2004-02-26 | Maria Clementine Martin Klosterfrau Vertriebsgesellschaft Mbh | Pharmazeutische Zusammensetzung zur Behandlung von Rhinitiden |
CN101175479A (zh) | 2005-03-16 | 2008-05-07 | 霍尼韦尔国际公司 | 药物递送制剂、装置和方法 |
DE102008036725B4 (de) * | 2008-08-07 | 2021-01-28 | Maria Clementine Martin Klosterfrau Vertriebsgesellschaft Mbh | Pharmazeutische Zusammensetzung für die nasale Applikation |
CN101756964A (zh) | 2008-11-20 | 2010-06-30 | 北京利乐生制药科技有限公司 | 一种含有盐酸赛洛唑啉的复方药用鼻腔喷雾剂 |
CN102361552A (zh) | 2009-03-23 | 2012-02-22 | 莱拉制药用品私营有限责任公司 | 用于治疗过敏性眼/鼻疾病的姜黄色素及其代谢物 |
-
2012
- 2012-03-20 DE DE102012005452A patent/DE102012005452A1/de active Pending
- 2012-03-20 DE DE202012002792U patent/DE202012002792U1/de not_active Expired - Lifetime
- 2012-09-25 WO PCT/EP2012/003995 patent/WO2013097911A1/de active Application Filing
- 2012-09-25 EP EP12766592.5A patent/EP2766008B1/de not_active Revoked
- 2012-09-25 PL PL12766592T patent/PL2766008T3/pl unknown
- 2012-09-25 DK DK12766592.5T patent/DK2766008T3/en active
- 2012-09-25 EP EP14182601.6A patent/EP2818163A1/de active Pending
- 2012-09-25 UA UAA201408502A patent/UA113749C2/uk unknown
- 2012-09-25 EA EA201491300A patent/EA024618B1/ru not_active IP Right Cessation
- 2012-09-25 ES ES12766592.5T patent/ES2612652T3/es active Active
- 2012-09-25 GE GEAP201213539A patent/GEP201706609B/en unknown
Also Published As
Publication number | Publication date |
---|---|
DE202012002792U1 (de) | 2013-01-03 |
EA024618B1 (ru) | 2016-10-31 |
ES2612652T3 (es) | 2017-05-18 |
EP2818163A1 (de) | 2014-12-31 |
DE102012005452A1 (de) | 2013-07-04 |
UA113749C2 (xx) | 2017-03-10 |
EP2766008A1 (de) | 2014-08-20 |
WO2013097911A1 (de) | 2013-07-04 |
EP2766008B1 (de) | 2016-11-02 |
PL2766008T3 (pl) | 2017-05-31 |
DK2766008T3 (en) | 2017-02-13 |
GEP201706609B (en) | 2017-01-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EA201491811A1 (ru) | АНТИ-LgR5 АНТИТЕЛА И ИММУНОКОНЪЮГАТЫ | |
CL2014003370A1 (es) | Composición acuosa estable de anticuerpos anti-baffr; y dispositivo de suministro de la composición. | |
EA201300388A1 (ru) | Соединения замещенного бензамида | |
EA202190619A1 (ru) | Противовирусные соединения | |
EA201491947A1 (ru) | Антитела и иммуноконъюгаты к ly6e и способы применения | |
PH12015500850A1 (en) | Stable preservative-free mydriatic and anti-inflammatory solutions for injection | |
EA201490420A1 (ru) | ЛЕЧЕНИЕ ЗАБОЛЕВАНИЙ, СВЯЗАННЫХ С α-СУБЪЕДИНИЦАМИ ПОТЕНЦИАЛЗАВИСИМЫХ НАТРИЕВЫХ КАНАЛОВ (SCNxA), С ПОМОЩЬЮ МАЛЫХ МОЛЕКУЛ | |
EA201590173A1 (ru) | Иммуноконъюгаты, содержащие антитела к cd22 | |
BR112014031310A2 (pt) | anticorpos anti-pcsk9, formulações, dosagem e métodos de uso | |
EA201490559A1 (ru) | Композиция для лечения свища | |
EA201590731A1 (ru) | Антитела к гемагглютинину и способы применения | |
BR112013031493A2 (pt) | composto, composição farmacêutica, uso de um composto, combinação de um composto, dispositivo e processo de preparação de um composto. | |
BR112013023056A2 (pt) | derivados de oxaespiro [2,5] octano e análogos | |
UY34582A (es) | Anticuerpos anti-cxcr3 | |
EA201491357A1 (ru) | Анти-lrp5 антитела и способы их применения | |
EA201490037A1 (ru) | Антагонисты trpv4 | |
CR20130147A (es) | Combinaciones que contienen n-(2-arilamino)arilsulfonamida sustituida | |
EA201590617A1 (ru) | Композиции алкилированного циклодекстрина и способы их получения и применения | |
EA201491300A1 (ru) | Композиция для назального применения с улучшенной стабильностью | |
EA201790410A1 (ru) | Содержащая цинеол композиция для назального применения | |
CO6920289A2 (es) | Composición farmacéutica oftalmológica tópica que contiene regorafenib. | |
CL2012001192S1 (es) | Botella. | |
TR201100148A2 (tr) | Stabil akarboz förmülasyonları. | |
EA201500313A1 (ru) | Стабилизированная аморфная форма агомелатина, способ ее изготовления и фармацевтические композиции, ее содержащие | |
EA201400444A1 (ru) | Производные 2-оксопиперидинила |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM4A | Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s) |
Designated state(s): AM AZ BY KZ KG TJ TM |